Abstract：Objective To investigate the roles of signal transduction and activator of transcription 6 (STAT6) and orosomucoid 1-like 3 (ORMDL3) in airway remodeling among asthmatic mice and to observe the effects of budesonide (BUD) on their expression. Methods Thirty BALB/c mice were randomly divided into control, asthma, and BUD intervention group. The mice were sensitized and challenged with ovalbumin (OVA) to establish a mouse model of asthma. The BUD intervention group received aerosol inhalation of BUD dissolved in normal saline 30 minutes before each OVA challenge, while normal saline was used instead of OVA solution in the control group. The pathological changes in the airway were observed by hematoxylin-eosin staining and Masson staining. The interleukin-13 (IL-13) level in lung homogenate was measured by enzyme-linked immunosorbent assay. The mRNA expression of STAT6 and ORMDL3 was measured by RT-PCR. Results The asthma group showed more pathological changes in the airway than the control and BUD intervention groups, and the BUD intervention group had reduced pathological changes in the airway compared with the asthma group. The asthma and BUD intervention groups had significantly higher IL-13 levels and mRNA expression of STAT6 and ORMDL3 than the control group (PPr=0.676, P=0.032). Conclusions STAT6 and ORMDL3 may be involved in the airway remodeling of mice, and BUD can reduce airway remodeling in asthmatic mice, possibly by down-regulating mRNA expression of STAT6 and ORMDL3.
ZOU Li-Ping,ZHANG Xi,ZHANG Yan et al. Down-regulatory effects of budesonide on expression of STAT6 and ORMDL3 in lung tissues of asthmatic mice[J]. CJCP, 2014, 16(2): 198-202.
Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma[J]. Nature, 2007, 448(7152): 470-473.
[2]
Yang G, Volk A, Petley T, et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling[J]．Cytokine, 2004, 28(6): 224-232．
Malmstrom K, Pelkonen AS, Malmberg LP, et al. Lung function, airway remodeling and inflammation in symptomatic inflants:outcome at 3 years[J]. Thorax, 2011, 66(2): 157-162.
[6]
Goleva E, Hauk PJ, Boguniewicz J, et al. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma[J]. J Allergy Clin Immunol, 2007, 120(5): 1065-1072.
[7]
Blease K, Schuh JM, Jakubzick C, et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma[J]. Am J Pathol, 2002, 160(2): 481-490.
[8]
Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease[J]. Nat Genet, 2008, 9(8): 955-962.
[9]
Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes[J]. Nat Genet, 2009, 9(6): 703-707.
[10]
Miller M, Tam AB, Cho JY, et al. ORMDL3 is an inducible lung epithelial gene regulating metalloproteases, chemokines, OAS, and ATF6[J]. Proc Natl Acad Sci U S A, 2012, 109(41): 16648-16653.
[11]
Cantero-Recasens G, Fandos C, Rubio-Moscardo F, et al. The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress[J]. Hum Mol Genet, 2010, 19(1): 111-121.
[12]
McGovern DP, Gardet A, Torkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci[J]. Nat Genet, 2010, 9(4): 332-337.
[13]
Mahn K, Hirst SJ, Ying S, et al. Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma[J]. Proc Natl Acad Sci U S A, 2009, 106(26): 10775-10780.
Qiu R, Yang Y, Zhao H, et al. Signal transducer and activator of transcription 6 directly regulates human ORMDL3 expression[J]. FEBS J, 2013, 280(9): 2014-2026.
